Lung & Mediastinal

Video
October 3, 2024 | Padungkiat Tangpiroontham

Conventional robotic-assisted subxiphoid thymectomy provides excellent visualization to both the phrenic nerve and the superior horn of the thymus gland, allowing the surgeon to effectively perform a radical thymectomy. However,...

Video
September 30, 2024 | Vincent GaudianiGold ContributorBronze Commentor

This video shows a 55-year-old patient who underwent an open pulmonary valvotomy in 1967. He presented with a 10cm right atrium, free pulmonary regurgitation, tricuspid regurgitation, and mitral regurgitation. First,...

Podcast
September 25, 2024 | Alice CopperwheatBronze Contributor

In this month’s episode of The Atrium, Dr. Alice Copperwheat explores chest drains with Leanne Ashrafian, thoracic surgeon and CTSNet Senior Editor. They discuss patient considerations, equipment used, positioning of...

Video
September 25, 2024 | Mostafa Eldewer

The patient was a 34-year-old male from Syria who presented with an incidental finding on his chest X-ray during a visa work up. Further testing revealed a 7.5 x 7.5...

Video
September 19, 2024 | Ahmad Ali AmirghofranBronze ContributorBronze Commentor

The minimally invasive approach has been utilized to correct numerous congenital cardiac anomalies, such as ASD, Partial AV canal, Subaortic web resection, VSD, and PAPVC with good results (1). This...

Video
September 18, 2024 | Hana Ajouz

A 64-year-old woman with a history of Stage IIIA adenocarcinoma of the left lower lobe underwent robotic-assisted left lower lobectomy and mediastinal node dissection in 2016, followed by adjuvant chemotherapy....

Video
September 11, 2024 | Amr Alsalakawy

Introduction Common arterial trunk (CAT) requires early surgical treatment to prevent high mortality and morbidity rates. The unopposed pulmonary overflow accelerates the deleterious effects of left-to-right shunting. Moreover, unprotected pulmonary...

Video
September 10, 2024 | Giovanni Mattioni

Since the publication of the results of the CheckMate 816 trial (1), neoadjuvant chemoimmunotherapy has been introduced as a standard of care for stage IB-IIIA resectable NSCLC without mutations. The...